By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aeras Global TB Vaccine Foundation 

1405 Research Blvd.

Rockville  Maryland  20850  U.S.A.
Phone: 301-547-2900 Fax: 301-547-2901


SEARCH JOBS



Segment
Research





Company News
Aeras Global TB Vaccine Foundation, GlaxoSmithKline (GSK) Collaborate on TB Vaccine 10/10/2012 7:41:14 AM
Aeras Global TB Vaccine Foundation and Infectious Disease Research Institute (IDRI) Sign Agreement to Jointly Develop Novel Tuberculosis Vaccine 5/10/2012 10:06:47 AM
Aeras Global TB Vaccine Foundation and CanSino to Collaborate on TB Vaccine Development 5/7/2012 10:12:39 AM
TapImmune Inc. (TPIV) and Aeras Global TB Vaccine Foundation Start Research & Development Collaboration 10/31/2011 10:02:02 AM
Aeras Global TB Vaccine Foundation and Crucell N.V. (CRXL) Announce Phase II Clinical Trial Start in Kenya 9/22/2010 11:34:19 AM
Aeras Global TB Vaccine Foundation And Crucell N.V. (CRXL) Announce Start of Phase II TB study in South Africa 4/14/2010 10:59:06 AM
TapImmune Inc. (TPIV) Signs R&D Collaboration Letter of Intent Agreement With Aeras Global TB Vaccine Foundation 2/1/2010 12:37:30 PM
Aeras Global TB Vaccine Foundation And Crucell N.V. (CRXL) Announce Start of TB Infant Study in South Africa 4/28/2009 10:58:05 AM
Aeras Global TB Vaccine Foundation and Crucell N.V. (CRXL) Announce TB Vaccine Clinical Trial in Kenya; Promising Vaccine Candidate Advances to Phase II Safety Study in South Africa 10/17/2008 8:18:34 AM
Emergent BioSolutions (EBS) and the University of Oxford form Joint Venture to Develop an Advanced Tuberculosis Vaccine with Funding from Wellcome Trust Sanger Institute and Aeras Global TB Vaccine Foundation 7/23/2008 10:09:17 AM
123
//-->